
Viveve Medical VIVE
Quarterly report 2022-Q3
added 11-10-2022
Viveve Medical Book Value 2011-2026 | VIVE
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Viveve Medical
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 15.1 M | 6.97 M | 16.5 M | 4.91 M | -2.6 M | -405 K | 3.94 M | -841 K | -6.64 M | -11.9 M | -4.09 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.5 M | -11.9 M | 1.9 M |
Quarterly Book Value Viveve Medical
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 1.18 M | 5.28 M | 10.2 M | 15.1 M | 20.4 M | 25.1 M | 27.5 M | 6.97 M | 6.97 M | 6.97 M | 6.97 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 4.91 M | 4.91 M | 4.91 M | 4.91 M | -2.6 M | -2.6 M | -2.6 M | -2.6 M | -405 K | -405 K | -405 K | -405 K | 3.94 M | 3.94 M | 3.94 M | 3.94 M | -841 K | -841 K | -841 K | -841 K | -7.31 M | -7.31 M | 1.56 M | 1.56 M | 1.09 M | 1.09 M | 1.09 M | 1.09 M | 3.55 M | 3.55 M | 3.55 M | 3.55 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 27.5 M | -7.31 M | 4.8 M |
Book Value of other stocks in the Medical devices industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
-1.42 M | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
196 M | - | - | $ 1.77 B | ||
|
Delcath Systems
DCTH
|
111 M | $ 9.13 | -0.76 % | $ 327 M | ||
|
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | ||
|
Lianluo Smart Limited
LLIT
|
272 M | - | 24.59 % | $ 44.8 M | ||
|
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
-879 K | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
25.5 M | - | -5.86 % | $ 30.6 M | ||
|
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.55 B | $ 9.38 | -1.78 % | $ 722 M | ||
|
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
15.7 M | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | ||
|
Inogen
INGN
|
192 M | $ 6.5 | 1.25 % | $ 173 M | ||
|
IRIDEX Corporation
IRIX
|
9.52 M | $ 1.35 | 1.89 % | $ 21.8 M | ||
|
IRadimed Corporation
IRMD
|
94.6 M | $ 98.74 | -2.99 % | $ 1.26 B | ||
|
OrthoPediatrics Corp.
KIDS
|
347 M | $ 16.35 | 0.74 % | $ 384 M | ||
|
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
58.1 M | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
6.23 M | - | 1.15 % | $ 34.5 M | ||
|
LENSAR
LNSR
|
18.6 M | $ 5.52 | -1.08 % | $ 63.6 M | ||
|
CONMED Corporation
CNMD
|
1.03 B | $ 36.64 | -1.19 % | $ 1.14 B | ||
|
Medtronic PLC
MDT
|
48.3 B | $ 87.67 | -0.24 % | $ 113 B | ||
|
Soliton, Inc.
SOLY
|
243 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
2.61 B | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
229 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
627 K | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
43.2 M | $ 24.45 | -0.85 % | $ 207 M | ||
|
Misonix, Inc.
MSON
|
30.4 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M | ||
|
Orthofix Medical
OFIX
|
450 M | $ 11.79 | -1.17 % | $ 467 M | ||
|
Outset Medical
OM
|
127 M | $ 3.52 | -0.28 % | $ 53.5 K | ||
|
Intersect ENT, Inc.
XENT
|
550 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
11.1 M | $ 0.6 | -10.61 % | $ 32.7 M | ||
|
Aethlon Medical
AEMD
|
5.12 M | $ 2.27 | -2.16 % | $ 3.54 M | ||
|
PAVmed
PAVM
|
-24 M | $ 8.94 | -3.87 % | $ 64.7 M | ||
|
BIOLASE
BIOL
|
1.96 M | - | -13.19 % | $ 166 K | ||
|
LivaNova PLC
LIVN
|
1.2 B | $ 63.65 | 0.55 % | $ 3.47 B | ||
|
InspireMD
NSPR
|
55.2 M | $ 1.73 | -2.26 % | $ 111 M | ||
|
Insulet Corporation
PODD
|
1.52 B | $ 218.11 | 0.98 % | $ 15.3 B | ||
|
AdaptHealth Corp.
AHCO
|
1.53 B | $ 11.41 | 0.18 % | $ 1.54 B | ||
|
Quanterix Corporation
QTRX
|
296 M | $ 3.9 | -1.52 % | $ 166 M | ||
|
Penumbra
PEN
|
1.43 B | $ 336.42 | 0.04 % | $ 13.1 B | ||
|
MiMedx Group
MDXG
|
257 M | $ 3.94 | -3.9 % | $ 582 M | ||
|
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
9.26 M | - | 10.0 % | $ 610 K | ||
|
Myomo
MYO
|
11.4 M | $ 0.68 | -2.2 % | $ 28.5 M | ||
|
Inspire Medical Systems
INSP
|
781 M | $ 50.45 | -1.87 % | $ 1.48 B |